Form 8-K - Current report:
SEC Accession No. 0001437749-20-001747
Filing Date
2020-02-05
Accepted
2020-02-05 09:33:17
Documents
25
Period of Report
2020-02-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20200205_8k.htm 8-K 22565
2 INVESTOR PRESENTATION ex_171499.htm EX-99.1 13864
3 a01.jpg GRAPHIC 186649
4 a02.jpg GRAPHIC 342923
5 a03.jpg GRAPHIC 252672
6 a04.jpg GRAPHIC 260510
7 a05.jpg GRAPHIC 298061
8 a06.jpg GRAPHIC 209679
9 a07.jpg GRAPHIC 177099
10 a08.jpg GRAPHIC 208764
11 a09.jpg GRAPHIC 217183
12 a10.jpg GRAPHIC 177527
13 a11.jpg GRAPHIC 224202
14 a12.jpg GRAPHIC 164482
15 a13.jpg GRAPHIC 177389
16 a14.jpg GRAPHIC 234538
17 a15.jpg GRAPHIC 233198
18 a16.jpg GRAPHIC 186683
19 a17.jpg GRAPHIC 288575
20 a18.jpg GRAPHIC 178943
21 a19.jpg GRAPHIC 278125
22 a20.jpg GRAPHIC 210729
23 a21.jpg GRAPHIC 198844
24 a22.jpg GRAPHIC 189088
25 a23.jpg GRAPHIC 107998
  Complete submission text file 0001437749-20-001747.txt   6928064
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 20576562
SIC: 2834 Pharmaceutical Preparations